High levels of ‘friendly fire’ from the body’s immune system can cause ‘long covit’

by

Scientists say that extreme levels of ‘friendly fire’ antibodies in the immune system can trigger ‘long cov’ by triggering severe corona virus symptoms.

Patients with coronavirus have high levels of ‘autoantibodies’ in their blood, which inhibit covid-coping antibodies in the body and attack many parts of the body, including the brain, blood vessels and liver.

This may be the reason why some Govt sufferers experience chronic symptoms – such as fatigue, shortness of breath and brain problems, a study has found.

Scientists say high levels of 'friendly fire' antibodies in the immune system can trigger 'long covit' by triggering severe corona virus symptoms (file image)

Scientists say high levels of ‘friendly fire’ antibodies in the immune system can trigger ‘long covit’ by triggering severe corona virus symptoms (file image)

Long Govt: What is it and can it be four different diseases?

Covit-19 SARS-CoV-2 is described as a short-term disease caused by an infection with the corona virus novel. Public health officials say people will recover within two weeks.

However, this does not apply to everyone, and it is clear that the two-week period is only the ‘acute illness’ phase.

The North Bristol NHS Trust’s Discover program, which studies the long – term effects of the corona virus, found that most (74 percent) of the total 110 patients admitted for a three – month trial had at least one persistent symptom after twelve. Weeks. The most common are:

  • Excessive fatigue: 39%
  • Shortness of breath: 39%
  • Insomnia: 24%
  • Muscle pain: 23%
  • Chest pain: 13%
  • Cough: 12%
  • Odor loss: 12%
  • Headache, fever, joint pain and diarrhea: less than 10% each

Other chronic symptoms reported by Covit-19 survivors include suspicious and confirmed, earlier hearing problems, ‘brain fog’, memory loss, lack of concentration, mental problems and hair loss.

The impact of Longcovite on mild disease has not yet been studied in depth.

Data from King’s College London Symptom Tracking App shows that up to 500,000 people in the UK are currently affected by the long-term effects of Covid-19.

In October, scientists said Longcovit could actually be divided into four different syndromes.

Educators for the National Health Research – led by Professor Chris Witty – were asked to review the limited evidence on the long cove to help patients and clinicians understand the ‘phenomenon’.

Their findings warn that even children may be at risk, and that those at low risk for acute illness and covit-19 death may not be considered at low risk for chronic side effects.

Doctors have warned of some mental health problems such as anxiety and depression in the ‘Long Howlers’, which, as they are known, may be below the locks as opposed to the virus.

Experts also say that the symptoms can be divided into four different groups:

  • Post-Acute Treatment Syndrome (PICS)
  • Post-viral fatigue syndrome (PVFS)
  • Permanent Organ Damage (POD)
  • Chronic Govt Syndrome (LTCS)

Yale University researchers calculated the number of ‘autoantibodies’ in the blood of 194 hospital staff and Govt patients – compared to 30 healthy staff.

They found that those without the infection had far fewer autoantibodies than those with the virus.

Another trial found that Govit sufferers had worse autoimmune antibodies that attack the same organs that are known to be damaged – experiencing worse Govt-19 symptoms.

Scientists fear that the negative effects of the ‘friendly fire’ may continue for a long time, causing a long cove.

Covit-19 SARS-CoV-2 is described as a short-term disease caused by an infection with the corona virus novel. Public health officials say people will recover within two weeks.

However, this does not apply to everyone, and it is clear that the two-week period is only the ‘acute illness’ phase.

The North Bristol NHS Trust’s Discover program, which studies the long – term effects of the corona virus, found that most (74 percent) of the total 110 patients admitted for a three – month trial had at least one persistent symptom after twelve. Weeks.

Aaron Ring, the Yale immunologist and senior author of the study, told The Guardian: ‘Covid-19 patients develop autoantibodies that actually interfere with the immune response to the virus.

We firmly believe that these autoantibodies may be harmful to Govit-19 patients.

‘Since antibodies can last a long time, it is conceivable that they may contribute to the development of chronic goiter.’

Antibodies are disease-fighting proteins that are produced and stored by the immune system to fight future invaders.

Autoantibodies, on the other hand, form the wrong form to bind, instead binding to proteins in human cells.

In the study, Dr. Ring – along with Professor of Immunology Biology Akiko Iwazaki – conducted the study, which has not yet been reviewed or published.

This follows the message that the chances of the Govt-19 vaccine being produced by Oxford University by the end of this year are ‘very high’.

The vaccine, which comes from Oxford and pharmaceutical company Astrogeneka, is not yet approved for use in the UK – the Drugs and Health Products Regulatory Agency (MHRA) is still reviewing test data.

The government has received 100 million doses of the vaccine, ready for four million key workers once approved.

Sarah Gilbert, a vaccine professor at Oxford University, says the chances of getting a jab – which is 90 percent effective and only costs $ 2 a dose – are ‘very high’ by the end of 2020.

But he stressed that many vaccines to combat the infection would be made using different technologies.

Professor Gilbert told the BBC’s Andrew Mar Show: ‘It depends on your age and JCVI (Joint Committee on Vaccines and Immunization) priorities.

Oxford University immunization professor Sarah Gilbert (pictured) said the chances of getting a jab by the end of 2020 were ‘very high’.

Oxford University immunization professor Sarah Gilbert (pictured) said the chances of getting a jab by the end of 2020 were ‘very high’.

‘I think the chances are very high. But we need many vaccines, all countries need many vaccines, the world needs many vaccines, if possible we need vaccines made using different technologies. ‘

This is because companies are having trouble delivering the raw materials, which will slow down the vaccine roll if other jabs are not available.

“So having so many shots on target, so many clay irons in the fire, we really need that,” he added.

Professor Gilbert’s optimistic estimate is that the burden of the corona virus case in the UK continues to rise – with a further 18,447 corona virus cases reported today, up from 1,175 last Sunday.

.Source

Leave a Comment